NFKB1 and cancer: In cancer, specifically, NF-κB activation is linked to apoptosis resistance as it negatively regulates anti-apoptotic proteins B-cell leukemia/lymphoma 2 (Bcl-2) and B-cell lymphoma-extra large (Bcl-XL).